๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Malignancies

A Phase I Study of ABSK211 in Participants With Advanced Solid Tumors With KRAS Alteration NCT07718165Phase 11 site๐Ÿ“ Shanghai Abbisko Therapeutics Co, Ltd ยท Tests: ABSK211 Efficacy and Safety of Concurrent PD-1 Inhibitor and Radiotherapy With Immunonutrition for Esophageal Squamous Cell Carcinoma NCT06342167Phase 210 sites๐Ÿ“ Beijing๐Ÿ“ Fujian๐Ÿ“ Handan Cancer Institute and Hospital, Chinese Academy of Medical Sโ€ฆ ยท Tests: Radiotherapy, Programmed Cell Death Protein 1 Inhibitor, Immunonutrition support A First-in-Human Study of BG-C0979 in Adults With Advanced Solid Tumors NCT07414836Phase 118 sites๐Ÿ“ Boston๐Ÿ“ St Louis๐Ÿ“ Hackensack BeOne Medicines ยท Tests: BG-C0979, Tislelizumab A Study to Evaluate Efficacy, and Safety of QL2107 Plus Chemo and Compare With Keytruda in Participants With IV nqNSCLC NCT06754644Phase 31 site๐Ÿ“ Jinan Qilu Pharmaceutical Co., Ltd. ยท Tests: QL2107, Pemetrexed, Carboplatin, Keytrudaยฎ Prediction of Outcome to Neoadjuvant Therapy in Non-small Cell Lung Cancer๏ผˆNSCLC๏ผ‰ NCT07388771n/a2 sites๐Ÿ“ Wuhan๐Ÿ“ Hangzhou Qian Chu Hypofractionated, 3-week, Preoperative Proton or X-ray Radiotherapy for Patients With Localized Soft Tissue Sarcoma NCT07169344Phase 24 sites๐Ÿ“ Bergen๐Ÿ“ Oslo๐Ÿ“ Tromsรธ Oslo University Hospital ยท Tests: preoperative, Quality of life, Functional outcome SBRT + PD-1 Antibody in Unresectable Locally Recurrent Rectal Cancer๏ผˆSPARKLE๏ผ‰ NCT06767007Phase 21 site๐Ÿ“ Guangzhou Sixth Affiliated Hospital, Sun Yat-sen University ยท Tests: Stereotactic Body Radiation Therapy (SBRT), PD1, Chemotherapy Long-term Follow-up of Anxiety and Depression in Patients With Malignant Tumors NCT05596344n/a1 site๐Ÿ“ Zhengzhou Henan Cancer Hospital ยท Tests: Hospital Anxiety and Depression Scale Preoperative Prediction of Lymph Node Metastasis in T1N0M0 Papillary Thyroid Carcinoma by Using Contrast-enhanced Ultrasound NCT07357571n/a2 sites๐Ÿ“ Guangdong๐Ÿ“ Guangzhou Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Standard Systemic Therapy Combined With High/Low-dose Radiotherapy Plus Toripalimab for Metastatic Colorectal Cancer NCT06525428Phase 21 site๐Ÿ“ Shanghai Fudan University ยท Tests: standard systemic therapy combined with high/low-dose radiotherapy plus toripalimab FaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma NCT04625907Phase 1, Phase 2128 sites๐Ÿ“ Brisbane๐Ÿ“ Camperdown๐Ÿ“ Clayton University of Birmingham ยท Tests: Irinotecan, Actinomycin D, Doxorubicin, Ifosfamide, Vincristine A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Endometrial Cancer. NCT06481592Phase 212 sites๐Ÿ“ Phoenix๐Ÿ“ Los Angeles๐Ÿ“ Orlando Iovance Biotherapeutics, Inc. ยท Tests: Lifileucel ChemoINTEL Assay Algorithm Development Study: In-Vitro Cytotoxic Drug Induced Apoptosis Correlation with Patient Clinical Response to Administered Chemotherapy in Patients NCT06844136n/a1 site๐Ÿ“ Liverpool Pierian Biosciences ยท Tests: No intervention Feasibility and Acceptability of Wearable Sensors and ePROs in Early Phase Clinical Trials NCT07541365NA1 site๐Ÿ“ Cleveland Case Comprehensive Cancer Center ยท Tests: Wearable actigraphy, Electronic Patient-Reported Outcomes (ePROs) Neoadjuvant Immunotherapy Plus Chemotherapy in Borrmann Type 4 and Large Type 3 Gastric Cancer NCT06451211Phase 21 site๐Ÿ“ Guangzhou Sun Yat-sen University ยท Tests: Tislelizumab, Oxaliplatin, S-1, Capecitabine Dose-escalation Study to Assess Safety and Pharmacokinetics of Nab-Sirolimus in Patients With Locally Advanced or Metastatic Solid Tumors and Moderate Liver Impairment NCT05661461Phase 12 sites๐Ÿ“ San Antonio๐Ÿ“ West Valley City Aadi Bioscience, Inc. ยท Tests: nab-sirolimus Pioglitazone-Metformin Combination Treatment for High Risk Oral Preneoplasia NCT05727761Phase 22 sites๐Ÿ“ Minneapolis๐Ÿ“ Saint Paul University of Minnesota ยท Tests: pioglitazone-metformin ABlative Radiotherapy (for) Unfavorable Prostate Tumors NCT04831983n/a1 site๐Ÿ“ Monza University of Milano Bicocca Aromatherapy Inhaler Use for HSCT Distress NCT05302583NA1 site๐Ÿ“ Stanford Stanford University ยท Tests: Aromatherapy Stick, Standard of Care "Xijiang Project" Screening Cohort for NPC NCT06787456n/a1 site๐Ÿ“ Zhuhai Ming-Yuan Chen ยท Tests: EBV antibodies test, EBV DNA test, epidemiological information survey, Clinical examinations for high-risk participantsโ€ฆ Reduced vs Conventional Dosage Intensity-modulated Radiotherapy for Chemotherapy-sensitive Stage II-III Nasopharyngeal Carcinoma NCT04448522Phase 36 sites๐Ÿ“ Guangzhou๐Ÿ“ Guangzhou๐Ÿ“ Shaoguan Sun Yat-sen University ยท Tests: reduced dosage IMRT, conventional dosage IMRT A Study to Assess the Safety and Efficacy of LB1410 in Participants With Advanced Solid Tumor or Lymphoma๏ผˆKeyplus-001๏ผ‰ NCT05357651Phase 11 site๐Ÿ“ Shanghai L & L Bio Co., Ltd., Ningbo, China ยท Tests: LB1410 Axillary Radiotherapy or Axillary Lymph Node Dissection in Patients With Clinically Node- Positive Breast Cancer Undergoing Upfront Tailored Axillary Surgery NCT07140172NA55 sites๐Ÿ“ Bethesda๐Ÿ“ Durham๐Ÿ“ Philadelphia University Hospital, Basel, Switzerland ยท Tests: Axillary lymph node dissection (ALND), Axillary radiotherapy (ART) Genetically-informed Therapy for ER+ Breast Cancer Post-CDK4/6 Inhibitor NCT05933395Phase 21 site๐Ÿ“ Lebanon Dartmouth-Hitchcock Medical Center ยท Tests: Fulvestrant, Neratinib, Alpelisib, Everolimus, Abemaciclib Elacestrant in Patients With ER+ HER2- ESR1-mutated Locally Advanced or Metastatic Breast Cancer NCT07563595n/a3 sites๐Ÿ“ Freiburg im Breisgau๐Ÿ“ Paderborn๐Ÿ“ Ravensburg iOMEDICO AG ยท Tests: Elacestrant, Standard of care (Investigator Choice) Yunzhi Essence to Improve the Quality of Life of Patients With Advanced Stage of Cancer NCT05754801Phase 21 site๐Ÿ“ Hong Kong Chinese University of Hong Kong ยท Tests: Yunzhi Essence, Placebo Irinotecan Liposome (II) or Etoposide Combined With Adebrelimab and Carboplatin in the Treatment of ES-SCLC NCT06739928Phase 21 site๐Ÿ“ Guangzhou Guangzhou Institute of Respiratory Disease ยท Tests: Irinotecan liposome (II) combined with adebrelimab and carboplatin, etoposide combined with adebrelimab and carboplatin A Study of BL-M05D1 in Patients With Locally Advanced or Metastatic Solid Tumors NCT06349811Phase 11 site๐Ÿ“ Beijing Sichuan Baili Pharmaceutical Co., Ltd. ยท Tests: BL-M05D1 Small Extracellular Vesicle miRNAs as Predictive Biomarkers for Immunochemotherapy Efficacy in Extensive-stage Small Cell Lung Cancer NCT07070011n/a1 site๐Ÿ“ Shanghai Shanghai Chest Hospital of Shanghai Jiao Tong University ยท Tests: EC/EP + ICIs Identification of Genetic, Phenotypic, Clinical, Biological and Histological Factors Differentiating Patients With Ovarian Cancer Who Are Refractory to Platinum-based Therapy From Patients Defined as Long-term Responders to Platinum-based Therapy NCT07361471NA1 site๐Ÿ“ Clermont-Ferrand Centre Jean Perrin ยท Tests: molecular analysis
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy